American International Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,802
| Closed | -$168K | – | 1975 |
|
|
2024
Q1 | $168K | Sell |
15,802
-136
| -0.9% | -$1.44K | ﹤0.01% | 2244 |
|
|
2023
Q4 | $146K | Buy |
15,938
+529
| +3% | +$4.83K | ﹤0.01% | 2348 |
|
|
2023
Q3 | $160K | Buy |
15,409
+3,563
| +30% | +$36.9K | ﹤0.01% | 2246 |
|
|
2023
Q2 | $170K | Buy |
11,846
+6
| +0.1% | +$86 | ﹤0.01% | 2271 |
|
|
2023
Q1 | $84.5K | Buy |
11,840
+236
| +2% | +$1.69K | ﹤0.01% | 2534 |
|
|
2022
Q4 | $130K | Buy |
11,604
+671
| +6% | +$7.53K | ﹤0.01% | 2383 |
|
|
2022
Q3 | $121K | Buy |
10,933
+155
| +1% | +$1.72K | ﹤0.01% | 2449 |
|
|
2022
Q2 | $91K | Buy |
10,778
+723
| +7% | +$6.1K | ﹤0.01% | 2654 |
|
|
2022
Q1 | $137K | Sell |
10,055
-708
| -7% | -$9.65K | ﹤0.01% | 2458 |
|
|
2021
Q4 | $212K | Sell |
10,763
-322
| -3% | -$6.34K | ﹤0.01% | 2334 |
|
|
2021
Q3 | $356K | Sell |
11,085
-263
| -2% | -$8.45K | ﹤0.01% | 2071 |
|
|
2021
Q2 | $384 | Buy |
11,348
+4,601
| +68% | +$156 | ﹤0.01% | 2093 |
|
|
2021
Q1 | $253 | Buy |
6,747
+502
| +8% | +$19 | ﹤0.01% | 2241 |
|
|
2020
Q4 | $207 | Sell |
6,245
-179
| -3% | -$6 | ﹤0.01% | 2271 |
|
|
2020
Q3 | $236K | Sell |
6,424
-146
| -2% | -$5.36K | ﹤0.01% | 2039 |
|
|
2020
Q2 | $216K | Buy |
6,570
+200
| +3% | +$6.58K | ﹤0.01% | 2076 |
|
|
2020
Q1 | $164K | Sell |
6,370
-368
| -5% | -$9.47K | ﹤0.01% | 2013 |
|
|
2019
Q4 | $210K | Buy |
+6,738
| New | +$210K | ﹤0.01% | 2192 |
|